US Stem Cell Inc (USRM)

[wallas2g1]

Whatever the merits of the FDAs case against USRM, one thing is clear for all to see i.e the science is promising and other players in the industry know this.

Best case scenario USRM prevails- etablishing itself as the industry leader it claims to be.

Worse case scenario USRM loses forcing it to partner with a bigger player to fund clinical trials in the US or concentrate on ex US expansion.

This is all very interesting. Either way, these prices won't last much longer IMO.